Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-004012-31Phase 4Terminated
Phase 4, open-label trial of oxygen in chronic kidney disease (CKD) (2 arms), sponsored by University Hospitals of Derby and Burton. Primary endpoints: Frequency of myocardial stunning, Severity of myocardial stunning and 1 more. Started Apr 2009; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-004012-31.